Related Experiment Videos
GOLD guidelines 2011: what are the implications for primary care?
1General Practitioner, Box, Wiltshire, UK. Kevin.Gruffydd-Jones@gp-J83013.nhs.uk
Insights
The revised 2011 Global Initiative for Chronic Obstructive Lung Disease guidelines offer a new COPD assessment tool, focusing on symptom reduction and future risk management for better patient care. These guidelines emphasize non-pharmacological strategies and co-morbidity treatment.
Area of Science:
- Pulmonology
- Respiratory Medicine
- Clinical Guidelines
Background:
- Chronic Obstructive Pulmonary Disease (COPD) is a multi-system disease.
- Previous management strategies did not fully address the systemic effects of COPD.
Purpose of the Study:
- To outline the major revisions in the 2011 Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines.
- To introduce a novel patient assessment approach for stable COPD management.
Main Methods:
- The revised guidelines utilize a novel assessment framework.
- Patients are categorized into four groups based on symptom burden and future risk (airflow limitation, exacerbation history).
- Pharmacotherapy strategies are tailored to these patient profiles.
Main Results:
- The guidelines integrate symptom assessment (mMRC, CAT) and risk assessment (airflow limitation, exacerbations).
- A pharmacotherapy strategy is presented based on the four identified patient groups.
- Non-pharmacological management emphasizes risk factor reduction (smoking cessation), exercise promotion, and immunizations.
- A new section addresses the assessment and treatment of co-morbid diseases.
Conclusions:
- The 2011 GOLD guidelines represent a significant advancement in COPD management.
- The guidelines promote a more holistic approach by considering COPD as a multi-system disease.
- Further development is needed to fully guide comprehensive COPD management in primary care settings.
Abstract:
A major revision of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines was published in December 2011, which takes account of the fact that chronic obstructive pulmonary disease (COPD) is a multi-system disease with effects on the patient beyond the effects of airflow limitation alone. The guidelines present a novel way of assessing the patient with COPD, linked to the major goals of stable COPD management of reducing symptoms (measured by the modified Medical Research Council Dyspnoea Score and/or COPD Assessment Tool) and reducing future risk (measured by the severity of airflow limitation and/or exacerbation history in the previous 12 months). Four patient groups are identified on the basis of their symptom/risk profile and a pharmacotherapy strategy is described using this profile. Emphasis is still placed on three pivotal features of non-pharmacological management: (1) reduction of exposure to risk factors (principally tobacco smoke); (2) promotion of exercise; and (3) immunisation against influenza and pneumococcal disease. In addition, there is a new chapter on the importance of assessing and treating co-morbid disease. The guidelines are a welcome advance in the management of COPD, but need further development to guide the more holistic approach to the management of patients with COPD in primary care.
Related Concept Videos
01:30Primary Healthcare Services
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
01:22Standards of Care I
01:19Standards of Care II
01:30Preventive Healthcare Services
01:06Legal Guidelines for Documentation
01:11Purpose of Health Records I
Here's a breakdown of how health records serve these purposes: